Search Results - "D. N. Andreev"

Rebamipide: evidence base for use in gastroenterology by Andreev, D N, Maev, I V

“…Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most…”
Get full text

Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years by Andreev, D N, Maev, I V, Kucheryavyy, Y A

“…Systematization of data on antibiotic resistance of Helicobacter pylori in Russia over the past 10 years. A search for studies were carried out in electronic…”
Get full text

Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis by Kucheryavyy, Y A, Andreev, D N, Maev, I V

“…Systematization of data on the frequency of detection of the syndrome of bacterial overgrowth in the small intestine (SIBO) in patients with functional…”
Get full text

Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice by Andreev, D N, Dicheva, D T, Maev, I V

“…A steady decline in the effectiveness of standard eradication therapy (ET) regimens for Helicobacter pylori infection necessitates a search for ways of their…”
Get full text

The prevalence of sarcopenia in patients with chronic pancreatitis: a meta-analysis by Maev, I V, Andreev, D N, Kucheryavyy, Y A, Levchenko, A I

“…Systematization of data on the prevalence of sarcopenia in patients with chronic pancreatitis (CP). MEDLINE/PubMed, EMBASE, Cochrane, the Russian Science…”
Get full text

Efficacy of butyric acid inclusion in eradication regimens for Helicobacter pylori infection: a meta-analysis of controlled trials by Andreev, D N, Kucheryavyy, Y A, Maev, I V

“…Systematization of data on the efficacy and safety of butyric acid inclusion in eradication therapy (ET) regimens for Helicobacter pylori infection. Research…”
Get full text

Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy by Maev, I V, Andreev, D N

“…In current clinical practice, there is no optimal empirical therapy for Helicobacter pylori (H. pylori) infection and there is a progressive decrease in the…”
Get full text

Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection by Maev, I V, Andreev, D N, Kucheryavyy, Yu A, Shaburov, R I

“…Gastroesophageal reflux disease (GERD) is characterized by high morbidity and a significant decrease in the quality of life of patients, and is a major risk…”
Get full text

Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C by Maev, I. V., Kuznetsova, E. I., Andreev, D. N., Dicheva, D. T.

“…Aim.Assessment of the diagnostic accuracy of predictive indexes of liver fibrosis for the identification of severe fibrosis and cirrhosis (F3F4) in patients…”
Get full text

Novel coronavirus infection COVID-19: extrapulmonary manifestations by Maev, I V, Shpektor, A V, Vasilyeva, E Y, Manchurov, V N, Andreev, D N

“…The novel coronavirus infection COVID-19 in most cases manifests with respiratory symptoms and fever, however, some patients may have cardiovascular and…”
Get full text

Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study by Andreev, D N, Maev, I V, Dicheva, D T, Samsonov, A A, Partzvania-Vinogradova, E V

“…To evaluate the effectiveness and safety of the use of rebamipide as part of the triple eradication therapy (ET) scheme of Helicobacter pylori infection. A…”
Get full text

The cardiovascular system in patients with functional and inflammatory bowel diseases by Maev, I V, Kazulin, A N, Andreev, D N

“…Identification of subclinical and metamanifests state changes of cardiovascular system in patients with functional and inflammatory bow- el diseases (IBD)…”
Get full text

The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease by Veliev, A M, Maev, I V, Andreev, D N, Dicheva, D T, Zaborovskii, A V, Lobanova, E G, Bektemirova, L G

“…Aim. Evaluation of the efficacy and safety of quadrupletherapy without bismuth (concomitant therapy) in patients with Helicobacter pylori - associated gastric…”
Get full text

Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease by Maev, I V, Barkalova, E V, Ovsepyan, M A, Kucheryavyi, Yu A, Andreev, D N

“…Gastroesophageal reflux disease (GERD) is a common condition that has a substantial impact on quality of life in patients and is a leading risk factor for…”
Get full text

Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results by Maev, I V, Andreev, D N, Govorun, V M, Ilina, E N, Kucheryavyy, Y A, Oganesian, T S, Melnikova, E V, Zayratyants, O V, Parfenova, T V, Dzhedzheia, L V, Kirillova, N V, Maevskaya, E A, Fomenko, A K, Lobanova, E G, Zaborovskii, A V, Kriukov, K A

“…Determine the primary antibiotic resistance of Helicobacter pylori (H. pylori) strains isolated from patients living in the European part of the Russian…”
Get full text

The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study by Bideeva, T V, Maev, I V, Kucheryavyy, Yu A, Andreev, D N, Shah, Yu S, Lobanova, E G, Zaborovskiy, A V, Levchenko, A I

“…Aim. The goal is to evaluate the effectiveness of pancreatic enzyme replacement therapy (PERT) using microencapsulated pancreatin preparations for the…”
Get full text

Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection by Yurenev, G L, Partzvania-Vinogradova, E V, Andreev, D N, Dicheva, D T, Maiev, I V

“…The aim is to conduct a comprehensive comparative study of the efficacy and safety of the hybrid scheme of eradication therapy (ET) in patients with peptic…”
Get full text

Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β by Bakulina, N V, Maev, I V, Savilova, I V, Bakulin, I G, Il'chishina, T A, Zagorodnikova, K A, Murzina, A A, Andreev, D N

“…Aim. To evaluate an association of genetic polymorphisms CYP2C19, MDR1, and IL-1β on the eradication rate by 10-day modified therapy in patients with H. pylori…”
Get full text

The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications by Ostroumova, O D, Kochetkov, A I, Pereverzev, A P, Kravchenko, E V, Kazjulin, A N, Andreev, D N, Pavleeva, E E

“…In the article the problem of the combined use of clopidogrel and various proton pump inhibitors (PPIs) in terms of cardiovascular complications risk and stent…”
Get full text

Cranial nerve monitoring in endoscopic endonasal surgery of skull base tumors (observing of 23 cases) by Shkarubo, A. N., Chernov, I. V., Ogurtsova, A. A., Chernov, V. E., Borisov, O. V., Koval, K. V., Andreev, D. N.

“…Background Preservation of anatomic integrity and function of the cranial nerves during the removal of skull base tumors is one of the most challenging…”
Get full text